Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

Item

http://www.wikidata.org/entity/Q58490177

description

im Mai 2011 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 05 May 2011

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в травні 2011

@uk

name

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@en

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@nl

type

Item

label

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@en

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@nl

prefLabel

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@en

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@nl

P1476

Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates

@en

P2093

Emmanuelle Pinjon

http://www.w3.org/2001/XMLSchema#string

Helena Bujdáková

http://www.w3.org/2001/XMLSchema#string

Naďa Kulková

http://www.w3.org/2001/XMLSchema#string

Silvia Borecká

http://www.w3.org/2001/XMLSchema#string

P2860

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

MDR1-mediated drug resistance in Candida dubliniensis

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis.

Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailin

Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole.

Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

P304

416-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1139/W11-025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Derek J. Sullivan

Karl Kuchler

Jaroslav Blaško

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21542785

http://www.w3.org/2001/XMLSchema#string